Gufic BioSciences Ltd share price was down by -1.43% from the previous closing price of ₹425.20. Who are peers of Gufic BioSciences Ltd? The peers of Gufic BioSciences Ltd are Sun ...

The Commodity Futures Trading Commission’s acting chair, Caroline Pham, removed the agency’s head of human resources, who was leading an internal investigation into staff complaints against ...

Google is revising its diversity, equity, and inclusion initiatives, dropping its previous goals for increasing hires from underrepresented groups. The reevaluation comes in response to federal ...

Atyr PHARMA has lower revenue, but higher earnings than Caribou Biosciences. Atyr PHARMA is trading at a lower price-to-earnings ratio than Caribou Biosciences, indicating that it is currently the ...

Carved with stone tools out of mammoth ivory, the tiny head measures just 1.9 inches (4.8 centimeters) tall and 1 inch (2.4 cm) wide. The sculpture appears to represent a woman's face, with ...

Brii Biosciences Limited, with a market cap of HK$872.45 million, is currently unprofitable and pre-revenue, generating CN¥38.38 million from its biotechnology startups segment.

Harmony Biosciences has a one year low of $28.14 and a one year high of $41.61. The stock’s 50 day moving average price is $34.46 and its 200 day moving average price is $34.96.

OpenAI says it trained a new AI model called GPT-4b micro with Retro Biosciences, a longevity science startup trying to extend the human lifespan by 10 years, according to the MIT Technology Review.

Weʼre unable to load stories right now.

Matt Beaudet, CEO of Araceli Biosciences, commented on the partnership: "VALID exemplifies innovation in biotech. They are generating experimental data using next-generation human disease models.